Airbus - Q1 FY2026 Earnings Analysis

Performance Highlights

Airbus reported Q1 2026 revenues of €12.7 billion, down 7% year-on-year, with EBIT Adjusted of €300 million — a 52% decline versus the €624 million recorded in Q1 2025 — as both metrics came in below consensus expectations. Reported EPS fell to €0.74 from €1.01, while free cash flow before customer financing deteriorated sharply to negative €2.5 billion against negative €310 million in the prior-year period.

The primary drag was the commercial aircraft division, where EBIT Adjusted collapsed 84% to €81 million on just 114 deliveries — 22 fewer than Q1 2025 — compounded by US dollar depreciation and a less favourable hedge rate. Defence and Space provided a meaningful offset, with EBIT Adjusted rising 69% to €130 million on 7% revenue growth driven by Air Power volumes, while Helicopters held relatively stable at €65 million despite higher R&D spend.

Management Outlook and Forward Catalysts

Management reaffirmed all three 2026 targets — approximately 870 commercial deliveries, ~€7.5 billion EBIT Adjusted, and ~€4.5 billion FCF before customer financing — signalling confidence that a heavily back-end-loaded delivery profile can absorb the weak Q1 start. The guidance explicitly incorporates currently applicable tariffs and assumes no further supply-chain or geopolitical disruptions, framing the remainder of the year as a ramp-up execution story.

The central investor debate for Q2 and beyond turns on whether the ~756 deliveries required across the remaining three quarters are achievable given that Pratt & Whitney engine availability remains the key A320 Family pacer for both 2026 and 2027. Bulls will point to the resolved China administrative delay — nearly 20 aircraft now resuming delivery — the contained panel quality issue expected to clear by end of Q2, and record net orders of 398 aircraft with a backlog of 9,037 units. Bears will focus on the €5.2 billion inventory build, the widening net cash erosion to €9.8 billion from €12.2 billion at year-end, and unresolved contractual disagreements with Pratt & Whitney that introduce delivery-phasing risk deep into 2027.